Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

Informacje o projektach programu „Horyzont 2020” , a teraz także streszczenia sprawozdań , są dostępne w serwisie CORDIS. Wszystkie projekty H2020 można pobrać z Portalu Otwartych Danych UE .

My refinements

Download results of this page

Filtruj wg:

Rodzaj treści

Projekt (20)
Streszczenie raportu (1)

Advanced search

Wyszukiwanie projektów i wyników

Results 1 - 10 of 21
12 3 > 
Gene flow from transgenic plants: evaluation and biotechnology
ID: QLK3-CT-2001-02242
Data rozpoczęcia: 2002-01-01, Data zakończenia: 2005-06-30
This project addresses the likelihood of gene transfer from transgenic (chloroplast) plants to environmental microorganisms. The objectives of this work are to understand and quantify gene transfer under optimum conditions and develop tools for reducing (or augmenting) this ge...
Record Number: 64189
Last updated on: 2005-04-12
Bio-imaging method for cellular protein uptake
Cellular uptake and trafficking of matrix proteins, such as enamel matrix derived proteins, was demonstrated after tagging the protein with a fluorescent marker FITC (fluorescein isothiocyanate), adding it to human periodontal ligament cells in cell medium, and following the f...
Record Number: 40848
Last updated on: 2006-08-01
Demonstration of the clinical utility of holotc as an early marker of vitamin b12 deficiency
ID: QLK3-CT-2002-01775
Data rozpoczęcia: 2002-10-01, Data zakończenia: 2006-03-31
Vitamin B12 deficiency occurs in 10% of the elderly (10 million in EU) and is associated with psychiatric morbidity (dementia and depression), costing EU many billions of ecru/year. Treatment is inexpensive and effective but identification of those needing therapy is hampered ...
Record Number: 69759
Last updated on: 2005-04-12
Reducing food processing waste
[PROJEKT] REPRO - Reducing food processing waste
ID: 6922
Data rozpoczęcia: 2005-02-01, Data zakończenia: 2008-01-31
There is great pressure from consumers and legislation (e.g. EC Landfill Directive) for food processors to reduce disposal of co-product wastes which are biologically complex, environmentally unfriendly, and often microbiologically unstable. REPRO addresses all requirements of...
Programme: FP6-FOOD
Record Number: 81227
Last updated on: 2013-03-26
Comparison and validation of novel pyrogen tests based on the human fever reaction
ID: QLK3-CT-1999-00811
Data rozpoczęcia: 2000-02-01, Data zakończenia: 2003-01-31
Pyrogen testing is a crucial safety control of drugs as well as innovative high- tech products such as medical, cellular therapies and species-specific agents (e.g. recombinant proteins). For most biologicals, especially blood-derived drugs, the rabbit animal experiment repres...
Record Number: 51987
Last updated on: 2005-04-12
Microalgae as cell factories for chemical and biochemical products
ID: QLK3-CT-2002-02132
Data rozpoczęcia: 2003-02-01, Data zakończenia: 2006-01-31
There is increasing interest throughout Europe in alternative methods of obtaining chemical and biochemical products. Scientists are increasingly turning to micro algae as a natural source of many useful products. They also have many other useful properties, e.g. as a food sou...
Record Number: 68982
Last updated on: 2005-04-12
Novel Reactor System for Utilisation of Unprocessed Biomass and Waste Fuels to Replace Fossil Fuels
ID: NNE5/255/2001
Data rozpoczęcia: 2002-01-01, Data zakończenia: 2005-04-30
The aim of this HOTDISC demonstration project is to design, manufacture, install, run and test a unit, which can handle and destroy (by a long burning retention time) various unprocessed lumpy size waste materials and biomass. When having a HOTDISC operating in symbiosis with ...
Programme: FP5-EESD
Record Number: 61323
Last updated on: 2003-09-05
A systematic and multidisciplinary approach towards understanding and therapy of the inborn lysosomal storage disease alpha-mannosidosis.
ID: QLK3-CT-2001-02458
Data rozpoczęcia: 2001-10-01, Data zakończenia: 2004-09-30
Alpha-mannosidosis is a rare, degenerative and chronic disease with multiple factors contributing to the degrees of progression. Since these patients are born healthy and exhibiting a slow progression of clinical symptoms, an effective therapy initiated at early age would cont...
Record Number: 59013
Last updated on: 2005-04-12
Therapeutic oligomers for in vivo targeted gene modification
ID: QLK3-CT-2000-00634
Data rozpoczęcia: 2001-02-01, Data zakończenia: 2004-01-31
We work towards a platform technology that allows high efficiency targeted gene modification, including repair of mutated genes in the genome of humans but also site specific autogenesis in living cells at will. For this aim we develop a novel class of sequence specific bioact...
Record Number: 54681
Last updated on: 2005-04-12
Anchored cAMP signalling - implications for treatment of human disease
ID: QLK3-CT-2002-02149
Data rozpoczęcia: 2002-11-01, Data zakończenia: 2005-12-31
Signalling pathways and networks involving the signal compound cAMP are involved in major chronic diseases within the European community such as HIV, cancer, diabetes type II, cardiovascular disease, and genetic diseases such as diabetes incipidus and muscular dystrophies. How...
Record Number: 64901
Last updated on: 2006-06-13
12 3 > 
List retrieved on: 2018-10-16
Śledź nas na: RSS Facebook Twitter YouTube Zarządzany przez Urząd Publikacji UE W górę